Literature DB >> 11877501

Sodium channel blocking actions of the kappa-opioid receptor agonist U50,488 contribute to its visceral antinociceptive effects.

X Su1, S K Joshi, S Kardos, G F Gebhart.   

Abstract

The goal of the present study was to determine whether the kappa-opioid receptor agonist (ORA) U50,488 attenuates behavioral and primary afferent nerve responses to noxious colorectal distension (CRD) by sodium channel blockade. We tested the analgesic kappa-ORA (+/-)-trans U50,488, its enantiomers (-)-trans (1S,2S)-U50,488 and non kappa-ORA (+)-trans (1R,2R)-U50,488, and/or its diastereomer (-)-cis (1S,2R)-U50,488 for their ability to attenuate visceromotor and pelvic nerve afferent fiber responses to noxious CRD in vivo and voltage-activated sodium current in colon sensory neurons in vitro. In unanesthetized rats, subcutaneous administration of U50,488, (1S,2S)-U50,488, and (1R,2R)-U50,488 attenuated the behavioral visceromotor response to noxious CRD; the rank order of potency was: (1S,2S)-U50,488 > U50,488 angle quotation mark, right (1R,2R)-U50,488. U50,488 and its stereoisomers also inhibited responses of decentralized pelvic nerve afferent fibers to noxious CRD in a dose-dependent manner. Cumulative doses of 16 mg/kg of (1S,2S)-U50,488, (1S,2R)-U50,488, and (1R,2R)-U50,488 reduced responses to a mean 29, 30, and 47% of control, respectively. The mean inhibitory doses of these drugs were not different (range: 6.6-10.8 mg/kg). Sodium channel blockers mexiletine and carbamazepine mimicked the effect of U50,488. In contrast, the kappa-ORAs dynorphin (1-13) and ICI 204,488 were ineffective in attenuating pelvic nerve activity. Perfusion of (1S,2S)-U50,488, (1S,2R)-U50,488, or (1R,2R)-U50,488 on colon sensory neurons in vitro decreased voltage-activated sodium currents. This inhibition by U50,488 and its stereoisomers was not opioid receptor-mediated because it could not be reversed by the opioid receptor antagonist naloxone and was also not a G protein-mediated effect. The results reported here suggest that the visceral antinociceptive effects of U50,488 and its stereoisomers are contributed to by their peripheral sodium channel blocking actions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877501     DOI: 10.1152/jn.00624.2001

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  15 in total

Review 1.  Peripheral kappa-opioid agonists for visceral pain.

Authors:  Pierre J-M Rivière
Journal:  Br J Pharmacol       Date:  2004-03-29       Impact factor: 8.739

2.  Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum.

Authors:  Andrew C Gray; Paul J White; Ian M Coupar
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

3.  Citronellol, a monoterpene alcohol, reduces nociceptive and inflammatory activities in rodents.

Authors:  Renan G Brito; Adriana G Guimarães; Jullyana S S Quintans; Marcio R V Santos; Damião P De Sousa; Daniel Badaue-Passos; Waldecy de Lucca; Fabíola A Brito; Emiliano O Barreto; Aldeídia P Oliveira; Lucindo J Quintans
Journal:  J Nat Med       Date:  2012-02-21       Impact factor: 2.343

4.  The κ-opioid receptor agonist U-50488 blocks Ca2+ channels in a voltage- and G protein-independent manner in sensory neurons.

Authors:  Bassil Hassan; Victor Ruiz-Velasco
Journal:  Reg Anesth Pain Med       Date:  2013 Jan-Feb       Impact factor: 6.288

5.  Early-in-life bladder inflammation alters U50,488H but not morphine-induced inhibition of visceromotor responses to urinary bladder distension.

Authors:  Amber D Shaffer; Timothy J Ness; Alan Randich
Journal:  Neurosci Lett       Date:  2012-11-29       Impact factor: 3.046

Review 6.  Visceral pain: the neurophysiological mechanism.

Authors:  Jyoti N Sengupta
Journal:  Handb Exp Pharmacol       Date:  2009

7.  Early in life bladder inflammation alters opioid peptide content in the spinal cord and bladder of adult female rats.

Authors:  Amber D Shaffer; Timothy J Ness; Meredith T Robbins; Alan Randich
Journal:  J Urol       Date:  2012-11-19       Impact factor: 7.450

Review 8.  Ionic storm in hypoxic/ischemic stress: can opioid receptors subside it?

Authors:  Dongman Chao; Ying Xia
Journal:  Prog Neurobiol       Date:  2009-12-28       Impact factor: 11.685

9.  Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review.

Authors:  Allen W Mangel; Gareth A Hicks
Journal:  Clin Exp Gastroenterol       Date:  2012-01-12

10.  From Acupuncture to Interaction between δ-Opioid Receptors and Na (+) Channels: A Potential Pathway to Inhibit Epileptic Hyperexcitability.

Authors:  Dongman Chao; Xueyong Shen; Ying Xia
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-03       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.